A Johns Hopkins analysis links lower vertebral bone density with faster cognitive decline and worsening white-matter integrity in regions supporting executive function.
On September 22, 2026, Radiology published a Johns Hopkins University-led secondary analysis of the Multi-Ethnic Study of Atherosclerosis. The paper examined structural associations between skeletal health and cognitive function in older adults. Researchers found that lower baseline thoracic vertebral bone mineral density was associated with faster global cognitive decline. The findings also linked lower bone density to worsening white-matter integrity in critical brain networks.
These affected brain networks specifically support executive function, working memory, and attention. These cognitive domains are essential for high-stakes decision making and sustained professional focus. A decline in these areas often translates to noticeable mental fatigue and reduced concentration during demanding workdays. This research suggests that skeletal imaging could eventually provide early warnings about these precise cognitive vulnerabilities.
To conduct this analysis, researchers utilized a deep-learning algorithm developed at Johns Hopkins University. This advanced tool estimated volumetric bone mineral density directly from noncontrast chest CT scans. The initial analysis began broadly and included 2,086 participants with these CT-derived vertebral measurements. The final study cohort was narrowed to 715 participants who had established bone density measurements alongside brain MRI and cognitive-testing data.
The study revealed specific physiological changes within the brain structure itself. Lower bone density was associated with a greater accumulation of white-matter hyperintensities in the corpus callosum. This major brain structure facilitates crucial communication between the left and right hemispheres. It is heavily involved in essential daily tasks like attention and working memory.
Lower bone density was also associated with a steeper decline in total white-matter fractional anisotropy. This specific decline occurred in the anterior limb of the internal capsule, a pathway heavily involved in executive function. Fractional anisotropy is an MRI-derived measure related to the organization and integrity of white-matter fibers. These specific structural metrics provide a more detailed picture of neurological health than standard cognitive testing alone.
The scope of this research highlights the complexity of measuring brain health in living patients. Cognitive testing provides a functional assessment of how the brain performs on specific tasks on a given day. In contrast, MRI metrics like white-matter hyperintensities reveal the underlying physical deterioration of the brain infrastructure over time. By combining these functional and structural measurements, the researchers created a more comprehensive model of neurological aging.
Shadpour Demehri, a Johns Hopkins professor of radiology, characterized this work as a pioneering longitudinal secondary analysis. He noted it is the first to link baseline vertebral bone mineral density with changes in white-matter structure and cognition. Demehri stated that the combination of imaging and clinical assessments sends a clear signal. That signal indicates baseline bone density is associated with functional and imaging measures of age-related brain degeneration.
Sara Momtazmanesh, the postdoctoral fellow who led the multidisciplinary team, highlighted the clinical utility of the method. She explained that chest CT scans could provide an opportunistic measurement of bone density from the thoracic spine. This opportunistic measurement is directly associated with a loss of cognitive function over time.
During the toughest quarter of my career, I noticed that my ability to handle stress was directly tied to my cardiovascular fitness. I was trying to meditate my way out of a physiological deficit. Once we started looking at the data connecting physical capacity to emotional regulation and executive function, everything clicked. Physical capacity is the absolute foundation of mental resilience.
This Johns Hopkins research reinforces that foundational reality by highlighting shared biological vulnerabilities. Demehri emphasized that the study is not about cause and effect. He suggested that shared metabolic drivers like insulin resistance and dyslipidemia could contribute to both bone and brain degeneration. Menopausal changes were also cited as a potential shared driver of these parallel aging processes.
High performers often view physical and mental capacities as separate accounts to be managed independently. This research definitively challenges that isolated approach by linking the skeleton directly to the brain's white-matter networks. Maintaining strength and metabolic health over time is not simply about physical appearance or cardiovascular endurance. It is a fundamental requirement for preserving the mental bandwidth needed to lead complex organizations through periods of high stress.
For busy professionals, this means cognitive longevity cannot be isolated from broader metabolic health. Protecting cognitive performance requires managing these systemic risk factors through a comprehensive cardiometabolic strategy. Executives should view bone health and focus and cognition within a unified framework rather than treating them as separate improvement projects. A lower bone density reading should simply serve as a risk signal to discuss with a qualified physician.
It is crucial to protect cognitive performance through established physical fundamentals while the scientific evidence develops. This study does not test supplements, nootropics, exercise programs, or specialized executive-performance protocols. Therefore, it cannot justify claiming that any specific intervention will reverse these precise imaging associations. Executives need high returns on minimum viable effort, and that begins with solid foundational metabolic health.
While the primary RSNA report summarizes the broad associations, secondary reporting offers specific statistical estimates. Earth.com described the association as approximately 0.025 standard deviations of additional annual global-cognition decline for every 0.1 g/cm³ decrease in density. This estimate is equivalent to roughly 0.15 standard deviations of cognitive decline over a five-year period. These precise numerical estimates should be rigorously checked against the full published paper before clinical application.
The same secondary report detailed the rate of structural brain changes observed in the study. It described a 12.8% faster annual accumulation of corpus-callosum white-matter hyperintensities for every 0.1 g/cm³ decrease in bone density. The primary RSNA report also noted that diabetes status showed effect modification for this white-matter-hyperintensity accumulation. Furthermore, participant sex showed suggestive effect modification for the observed fractional-anisotropy changes.
The study utilized different subsets of participants for these various statistical analyses. The global cognitive-composite analysis shown in the central study figure included 639 participants. Longitudinal white-matter-hyperintensity data were only available for 408 participants in the cohort. Finally, fractional-anisotropy data were available for exactly 405 participants.
At ExecuFuel, we prioritize intellectual honesty when evaluating any scientific literature regarding executive longevity. This specific research was a secondary analysis of an existing observational cohort rather than a controlled trial. The association therefore does not establish that low bone density causes cognitive decline, white-matter injury, or dementia. The researchers explicitly cautioned that these findings do not show that osteoporosis causes dementia.
Important statistical context is also missing from the publicly available RSNA summary. The report does not provide full regression models or follow-up durations. It also omits confidence intervals, p-values, and participant age distributions. These significant omissions limit how precisely readers can judge the clinical magnitude of the associations from the news release alone.
Other unreported or incompletely characterized health factors could also easily influence both skeletal density and cognitive trajectories. The study does not show that routinely scanning healthy people strictly for cognitive-risk prediction improves long-term outcomes. The different sample sizes across the various analyses mean the findings were not necessarily based on the exact same participants. A lower vertebral bone density measurement should prompt appropriate clinical follow-up rather than immediate panic, as it is not evidence that a founder or executive is inherently destined for irreversible cognitive decline.
This study reflects a growing medical movement toward extracting additional biological signals from existing imaging. AI models can now estimate vertebral bone density using chest CTs that were originally acquired for entirely different clinical purposes. These scans are often obtained for lung-cancer screening, coronary-calcium scoring, or pulmonary-nodule follow-up. This opportunistic approach gathers valuable preventative data without requiring a separate dedicated bone-density examination.
A separate Radiology study reported by RSNA in September 2026 provided additional context for this movement. That research found that subclinical emphysema-like changes visible on chest CT may help warn of accelerated vertebral bone loss. This finding was observed in people without diagnosed COPD. While adjacent to the Johns Hopkins cognition study, these reports illustrate how one scan may eventually support multi-organ risk assessment.
The medical field is increasingly finding opportunities to connect age-related conditions across multiple organ systems. Clinicians are moving away from examining skeletal, vascular, pulmonary, and neurological health in absolute isolation. White-matter hyperintensities are associated with memory loss and dementia risk, making this imaging trend highly relevant to cognitive-health monitoring. However, the presence or progression of such lesions is not equivalent to a formal diagnosis of dementia.
Before broad clinical adoption can occur, researchers will need to achieve external validation and standardized measurement protocols. They must secure evidence of incremental predictive value and conduct prospective studies showing that acting on this information benefits patients. AI-assisted analysis may eventually make it much easier to identify people who merit earlier clinical assessment. Until that time, the current evidence supports careful triage and continued research rather than autonomous diagnosis.
Stay connected for research and practical guidance on executive performance, energy, focus, sleep, recovery and longevity. Ideas built for people who want to stay sharp, capable and effective for the long run.
Build habits and systems that support clear thinking, steady energy and long term capacity throughout a demanding career.
explore the Blog
